China eliminates import duties on 28 Indian medicines

May 8, 2018

China has exempted import tariffs (duties) for 28 drugs, including all cancer drugs, from May 1st China has removed import duties on as many as 28 medicines, including all cancer drugs, from May 1, a move which would help India to export these pharmaceuticals to the neighbouring country. The development assumes significance as India has time and again asked for greater market access for its goods and services, including IT, pharmaceuticals and agriculture, in the Chinese market to reduce the widening trade deficit. In the meeting of India China Joint Group on Economic Relations, Trade, Science and Technology, the issue ...

Read More

EMA to review sotagliflozin as potential treatment for type 1 diabetes

Mar 29, 2018

The European Medicines Agency (EMA) has accepted for review Sanofi’s regulatory submission for sotagliflozin. If approved, the oral treatment would be used as an addition to insulin therapy to improve blood sugar control in adults with type 1 diabetes mellitus. Developed in partnership with Lexicon Pharmaceuticals, Inc., sotagliflozin is an investigational dual inhibitor of SGLT-1 and SGLT-2, proteins that influence how the intestines and kidneys process blood sugar (glucose).   “Despite recent advances, the challenges of type 1 diabetes management prevent many patients from reaching their treatment goals. There is a need for therapies to be used in addition to ...

Read More

What Does the Falsified Medicines Directive (FMD) Mean for SMEs and CMOs; and More Importantly, Are These Organisations Ready?

Jan 4, 2018

The implications of the directive are far-reaching and affect all pharmaceutical manufacturers, regardless of size. As time runs out and the deadline grows ever closer, Christian Taylor of Zetes explains in his article how CMOs and SME pharmaceutical manufacturers can ensure they are compliant. If smaller organisations embrace the regulatory changes – using them as an opportunity to optimise their supply chains, they can create true business value, making it pay to be compliant. ...

Read More

Cardiabase, a Banook Group company, supports the World Health Organization (WHO) in the fight against malaria

Nov 29, 2017

Cardiabase, a Banook Group company, the global provider of cardiac safety, central imaging and endpoint adjudication services for clinical trials, today announces that it has been supporting the World Health Organization (WHO) in the fight against malaria with the full agreement of the promoters of the clinical studies concerned. The company is able to provide the WHO with relevant and up-to-date information on the cardiotoxicity of antimalarial drugs when evaluating new malaria treatments in development. It can also provide crucial information for malaria management recommendations that the WHO publishes on a regular basis. Malaria is an infectious disease caused by ...

Read More

Tjoapack launches new bottle packing line

Nov 29, 2017

Contract packaging organisation (CPO), Tjoapack, has launched its new bottle packing line following a major investment earlier this year. The new line, which is now operational at its facility in Etten-Leur, the Netherlands, triples the CPO’s capacity using high-throughput technology and caters for the growing demand for bottle packing services in Europe. Tjoapack, which specialises in primary packaging for solid dosage forms, unit dose packaging and secondary packaging, now has 19 packaging lines for blisters, wallets and bottles and supplies to customers in over 40 countries across Europe, North & South America, Asia and Africa. Dexter Tjoa, director corporate strategy ...

Read More